# The Treatment of Sepsis Induced Myocardial Dysfunction With Yiqilishui Formula

> **NCT06686355** · PHASE2 · RECRUITING · sponsor: **Dongzhimen Hospital, Beijing** · enrollment: 80 (estimated)

## Conditions studied

- Sepsis Induced Myocardial Dysfunction

## Interventions

- **DRUG:** Yiqilishui formula
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06686355
- **Lead sponsor:** Dongzhimen Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-20
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06686355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06686355, "The Treatment of Sepsis Induced Myocardial Dysfunction With Yiqilishui Formula". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06686355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*